NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









First Ascent Biomedical

First Ascent Biomedical

Private
Miami, FloridaHealthcare & Life Scienceshttps://firstascentbiomedical.com

Last Round

Grant

Mar 7, 2025

Total Funding Raised

$10M

Momentum Score

50 /100

Company Overview

First Ascent Biomedical is a biotechnology company that has developed a drug prediction platform designed to provide personalized treatment planning for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Drug Discovery, Biotechnology, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

functional precision medicineoncology decision supportex vivo drug sensitivity testingpersonalized cancer treatmentlive-cell drug testingchemosensitivity testingcancer therapy selectionAI in oncologyprecision oncologydrug response predictiontumor profilingdrug discovery servicesrefractory cancersolid tumor testingliquid biopsyCLIA-validated labpediatric oncology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

First Ascent Biomedical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

First Ascent Biomedical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMar 7, 2025
GrantMar 3, 2025
Early FundingJan 13, 2025

Key People

Founding team and executive leadership

Noah Berlow

Chief Technology Officer

Executive Team

Izack Bailey

Chief Financial Officer

Executive Team

First Ascent Biomedical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 22, 2025

    Attended the 2025 CancerX Accelerator Showcase in Boston.

  • Jul 22, 2025

    Won the People's Choice Award at the CancerX Accelerator Showcase.

First Ascent Biomedical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

First Ascent Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about First Ascent Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range17
Year Founded2018
Last FundingMar 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.